- Advanced Radiotherapy Techniques
- Radiation Therapy and Dosimetry
- Childhood Cancer Survivors' Quality of Life
- Advances in Oncology and Radiotherapy
- Radiation Dose and Imaging
- Glioma Diagnosis and Treatment
- Bone Tumor Diagnosis and Treatments
- Medical Imaging Techniques and Applications
- Sarcoma Diagnosis and Treatment
- Palliative Care and End-of-Life Issues
- Head and Neck Cancer Studies
- Nonmelanoma Skin Cancer Studies
- Brain Metastases and Treatment
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- Hepatocellular Carcinoma Treatment and Prognosis
- Radiomics and Machine Learning in Medical Imaging
- Prostate Cancer Diagnosis and Treatment
- Testicular diseases and treatments
- Head and Neck Surgical Oncology
- Health Systems, Economic Evaluations, Quality of Life
- Medical Imaging and Analysis
- Ear and Head Tumors
- Cancer Diagnosis and Treatment
- Oral and Maxillofacial Pathology
Royal Adelaide Hospital
2019-2025
University of South Australia
2020-2025
South Australian Health and Medical Research Institute
2023-2025
Hudson Institute
2023
The University of Adelaide
2020-2022
Gold Coast Hospital
2017-2020
The University of Queensland
2014-2017
Royal Australian and New Zealand College of Radiologists
2017
Toowoomba Hospital
2015-2016
Mater Misericordiae Hospital
2016
A 35-year-old male bodybuilder was found to have a hepatocellular carcinoma (HCC) arising in pre-existing hepatic adenoma following recreational anabolic steroid use. Given the widespread use of steroids, another potentially life-threatening complication is highlighted addition more commonly recognised adenoma. Malignant transformation HCC from confirmed by immunohistochemical study has previously not been reported athletes taking steroids. Further studies using screening programmes identify...
Background and purposeThe [18]F-fluoroethyl-L-tyrosine (FET) PET in Glioblastoma (FIG) study is an Australian prospective, multi-centre trial evaluating FET for newly diagnosed glioblastoma management. The Radiation Oncology credentialing program aimed to assess the feasibility Oncologist (RO) derivation of standard-of-care (MR) hybrid (MR + FET) target volumes, which incorporated pre-defined biological tumour volumes (BTVs).Materials methodsCentral review analysis MR-derived (TVMR)...
Abstract With the anticipated launch of Australian Bragg Centre for Proton Therapy and Research (ABCPTR) in Adelaide, Australia, proton therapy will become a significant addition to existing cancer treatment options Australians. The benefits be particularly evident rare cancers such as clival chordomas, challenging tumour entity due anatomical relationship with critical structures, proven radio‐resistance conventional radiation therapy. article synthesises key findings from major studies...
We report on learning outcomes of a standardized national education program aimed at improving general practitioner (GP) knowledge about radiation therapy (RT) and referral pathways to oncologists (ROs).In 2014, GP was developed through the Targeting Cancer public awareness campaign Royal Australian New Zealand College Radiologists (RANZCR) Faculty Radiation Oncology. The sessions were held in RT departments comprised RO-led case-based group department tour. Pre- immediate post-session...
Osteoradionecrosis (ORN) of the chest wall is a rare complication after whole-breast radiotherapy (RT). Herein, we report case ORN involving underlying ribs following adjuvant RT using standard fractionation and conduct review literature.
Optical scanning technologies are increasingly being utilised to supplement treatment workflows in radiation oncology, such as surface-guided radiotherapy or 3D printing custom bolus. One limitation of optical devices is the absence internal anatomical information patient scanned. As a result, conventional therapy planning using this imaging modality not feasible. Deep learning useful for automating various manual tasks most notably, organ segmentation and planning. models have also been...
Abstract Introduction Construction of the first Australian particle therapy (PT) centre is underway. Establishment a national registry, to be known as Particle Therapy Clinical Quality Registry (ASPIRE), has been identified mandatory requirement for PT treatment reimbursed by Medicare Benefits Schedule. This study aimed determine consensus set Minimum Data Elements (MDEs) ASPIRE. Methods A modified Delphi and expert process was completed. Stage 1 compiled currently operational...
Proton-to-photon comparative treatment planning is a current requirement of Australian Government funding for patients to receive proton beam therapy (PBT) overseas, and future Medicare PBT in Australia. Because the fundamental differences plan creation evaluation between conventional radiation with x-rays (XRT), there potential lack consistency process comparing XRT plans. This may have an impact on patient eligibility assessment PBT. The objective these guidelines provide practical...
Abstract Introduction Travelling for cancer treatment comes with unique challenges, particularly a young patient and his or her family. The aims of this study were to (1) gain an understanding the experiences families patients who travelled overseas (OS) from Australia proton beam therapy (PBT) (2) identify supportive care needs their require when living away home, while having PBT. Methods This was retrospective, qualitative using semi‐structured interviews, conducted participants aged...
Cutaneous squamous cell carcinoma with large nerve perineural (LNPN) infiltration of the base skull is a radiotherapeutic challenge given complex target volumes to nearby organs at risk (OAR). A comparative planning study was undertaken evaluate dosimetric differences between volumetric modulated arc therapy (VMAT) versus intensity radiation (IMRT) in treatment LNPN.Five consecutive patients previously treated IMRT for LNPN were selected. VMAT plans generated each case using same (PTV), dose...
Background: Skin cancer is the most common malignancy that managed in general practice, and non-melanoma skin (NMSC) comprises vast majority of presentations. Radiation therapy (RT) plays an important part management NMSC may be used as definitive treatment for low-risk cancers, adjuvant high-risk disease or alone inoperable cases. Objective: The aims this article are to discuss: 1) types RT; 2) role RT, including its advantages disadvantages; 3) side effects (toxicity) 4) outcomes from 5)...